SCHEMBL8971056

SCHEMBL8971056

CC1C2=C(CCCC2)C(=O)N1CC1CCN(CCc2ccccc2)CC1

nearest known ligand 0.77

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CCR3 P51677 3/20 0.77
ACHE P22303 1/20 0.51
CARM1 Q86X55 1/20 0.44
PRMT6 Q96LA8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8971264 0.77 CCR3 (0.53) CCR3ACHE
SCHEMBL9599982 0.75 CCR3 (0.55) CCR3ACHE
SCHEMBL9599973 0.74 CCR3 (0.54) CCR3ACHE
SCHEMBL8971088 0.73 CCR3 (0.57) CCR3ACHE
SCHEMBL8971084 0.73 CCR3 (0.57) CCR3ACHE
SCHEMBL8971012 0.73 ADRA1D (0.61) CCR3ACHE
SCHEMBL8971112 0.71 L3MBTL1 (0.55) CCR3ACHE
SCHEMBL29381887 0.71 CCR3 (0.75) CCR3ACHECARM1PRMT6
SCHEMBL9427625 0.70 CCR3 (0.56) CCR3ACHE
SCHEMBL9427623 0.70 CCR3 (0.56) CCR3ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5480892-A SIGMA RECEPTOR ANTAGONISTS; TREATMENT OF PHYSIOLOGICAL OR DRUG INDUCED PSYCHOSIS AND DYSKINESIA THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-01-02 US disclosed
US-5356906-A (N-phthalimidoalkyl) piperidines useful as treatments for psychosis THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1994-10-18 US disclosed